Where is the live CopyMark page for USPTO serial 76372887?

The live record is at https://getcopymark.com/trademark/76372887. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns SHARP SOLUTIONS?

According to the public USPTO record for serial number 76372887, the listed owner(s) include: IRIX PHARMACEUTICALS, INC., IRIX Pharmaceuticals, Inc., IRIX Pharmaceuticals, Inc..

What is USPTO serial number 76372887?

Serial number 76372887 is the USPTO application identifier for the mark SHARP SOLUTIONS. It is used to track examination, publication, and registration of this trademark.

What is the current status of SHARP SOLUTIONS?

SHARP SOLUTIONS (76372887) currently shows USPTO status code 711 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover SHARP SOLUTIONS?

The public record lists International Classes: 040, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: SHARP SOLUTIONS Serial# 76372887 | status 711; last event C7.. | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SHARP SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

IRIX PHARMACEUTICALS, INC.
Florence, SC
Other trademarks owned by IRIX PHARMACEUTICALS, INC.
IRIX Pharmaceuticals, Inc.
Florence, SC
Other trademarks owned by IRIX Pharmaceuticals, Inc.
IRIX Pharmaceuticals, Inc.
Florence, SC
Other trademarks owned by IRIX Pharmaceuticals, Inc.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL E. WEVER

MICHAEL E WEVER NELSON MULLINS RILEY & SCARBOROUGH LLP1320 MAIN ST FL 17COLUMBIA, SC 29201-3256UNITED STATES

Goods and services

Class	Description	Status	First use
040	small scale custom manufacture for others of active ingredients that are used in the production of pharmaceuticals	SECTION 7(e) - CANCELLED	Apr 1, 1997
042	pharmaceutical research and development; process engineering	SECTION 7(e) - CANCELLED	Apr 1, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 4, 2005	C7..	CANCELLED SECTION 7-TOTAL	—
Nov 30, 2004	C7RF	REQUEST FOR SECT 7 TOTAL SURRENDER FILED	—
Nov 30, 2004	MAIL	PAPER RECEIVED	—
Apr 27, 2004	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2003	ETOF	EXTENSION OF TIME TO OPPOSE RECEIVED	—
Apr 15, 2003	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2003	NPUB	NOTICE OF PUBLICATION	—
Feb 8, 2003	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Feb 6, 2003	CNEA	EXAMINERS AMENDMENT MAILED	—
Dec 23, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 23, 2002	MAIL	PAPER RECEIVED	—
Jun 26, 2002	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2002	DOCK	ASSIGNED TO EXAMINER	—
Jun 10, 2002	DOCK	ASSIGNED TO EXAMINER	—

SHARP SOLUTIONS